Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 62

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin

Vrijens, Bernard, Belmans, Ann, Matthys, Katelijne, Klerk, Erik de, Lesaffre, Emmanuel · 2006 · Pharmacoepidemiology and Drug Safety

Abstract

Aims: Correct execution of prescribed dosing regimen(s) is essential for patients to benefit from lipid lowering treatments. The objective of this study was to estimate the effect of a pharmaceutical care program on the adherence of once‐daily atorvastatin treatment in patients with elevated cholesterol levels. Methods: In both linguistic regions of Belgium, two districts were randomized between usual care and a supportive intervention program. Eligible patients included hyperlipemic subjects taking atorvastatin for at least 3 months. ‘Adherence’ was defined as the proportion of days during which the electronic device record showed that the patient had taken the daily dose. ‘Persistence’ quantifies how long the treatment is executed. Results: A total of 392 patients from 35 pharmacies were included in the intent‐to‐treat (ITT) analysis of the data (194 patients received intervention and 198 in the control group). The intervention resulted in a 6.5% increase in post‐baseline adherence (p < 0.001) mainly driven by a 13% increase in persistence at 1 year (p = 0.002). Conclusion: A supportive pharmaceutical care program consisting of review by patient and pharmacist of each patient's electronically compiled dosing history, plus educational reminders, improves patient adherence to the once‐daily atorvastatin dosing regimen, mainly by extending persistence. Copyright © 2005 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pds.1198

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 7

  1. The Lipid Research Clinics Coronary Primary Prevention Trial results: (I), 1984, Reduction in incidence of coronary heart disease; (II) The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA, 251, 351
  2. 10.1046/j.1524-4733.2000.36006.x · DOI
  3. 10.1001/jama.288.4.455 · DOI · Paper page
  4. 10.1016/S0140-6736(03)12948-0 · DOI · Paper page
  5. Scandinavian Simvastatin Survival Study Group, 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet, 344, 1383
  6. 10.1001/jama.1989.03420220087032 · doi:10.1001/jama.1989.03420220087032 · Paper page
  7. 10.1016/S0197-2456(00)00088-X · DOI

Cited by

See all 62

Metadata

Authors
Vrijens, B., Belmans, A., Matthys, K., Klerk, E. D., & Lesaffre, E.
Venue
Pharmacoepidemiology and Drug Safety
Publisher
Wiley
Published
2005-12-12
Volume
15
Issue
2
Pages
115-121
ISSN
  • 1053-8569
  • 1099-1557
Cited by
62
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. https://app.cochat.ai/papers/10.1002/pds.1198
The paper
Vrijens, B., Belmans, A., Matthys, K., Klerk, E. D., & Lesaffre, E. (2006). Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.1198

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.